1. Home
  2. VRTX vs AMAT Comparison

VRTX vs AMAT Comparison

Compare VRTX & AMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTX
  • AMAT
  • Stock Information
  • Founded
  • VRTX 1989
  • AMAT 1967
  • Country
  • VRTX United States
  • AMAT United States
  • Employees
  • VRTX N/A
  • AMAT N/A
  • Industry
  • VRTX EDP Services
  • AMAT Semiconductors
  • Sector
  • VRTX Technology
  • AMAT Technology
  • Exchange
  • VRTX Nasdaq
  • AMAT Nasdaq
  • Market Cap
  • VRTX 115.6B
  • AMAT 126.7B
  • IPO Year
  • VRTX 1991
  • AMAT N/A
  • Fundamental
  • Price
  • VRTX $444.23
  • AMAT $161.73
  • Analyst Decision
  • VRTX Buy
  • AMAT Buy
  • Analyst Count
  • VRTX 26
  • AMAT 22
  • Target Price
  • VRTX $512.54
  • AMAT $205.18
  • AVG Volume (30 Days)
  • VRTX 2.1M
  • AMAT 7.1M
  • Earning Date
  • VRTX 05-05-2025
  • AMAT 05-15-2025
  • Dividend Yield
  • VRTX N/A
  • AMAT 1.17%
  • EPS Growth
  • VRTX N/A
  • AMAT N/A
  • EPS
  • VRTX N/A
  • AMAT 8.22
  • Revenue
  • VRTX $11,099,700,000.00
  • AMAT $28,089,000,000.00
  • Revenue This Year
  • VRTX $10.36
  • AMAT $7.94
  • Revenue Next Year
  • VRTX $10.61
  • AMAT $6.13
  • P/E Ratio
  • VRTX N/A
  • AMAT $19.16
  • Revenue Growth
  • VRTX 8.98
  • AMAT 5.99
  • 52 Week Low
  • VRTX $377.85
  • AMAT $123.74
  • 52 Week High
  • VRTX $519.88
  • AMAT $255.89
  • Technical
  • Relative Strength Index (RSI)
  • VRTX 44.94
  • AMAT 53.34
  • Support Level
  • VRTX $427.43
  • AMAT $155.66
  • Resistance Level
  • VRTX $448.00
  • AMAT $166.29
  • Average True Range (ATR)
  • VRTX 11.02
  • AMAT 3.82
  • MACD
  • VRTX 0.83
  • AMAT -0.90
  • Stochastic Oscillator
  • VRTX 88.27
  • AMAT 38.30

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About AMAT Applied Materials Inc.

Applied Materials Inc is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.

Share on Social Networks: